GSK retains No 1 position, as Novartis overtakes J&J to take 2nd place. Takeda jumps 10 places to 5th.
Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018
Published in Industry News
More from Industry NewsMore posts in Industry News »
- FDA panel endorses booster shot for J&J Covid-19 vaccine
- Intas launches the World’s first SB-100mg Itraconazole
- Second J&J COVID-19 shot gets expert backing; FDA is looking at lowering age for Pfizer booster
- StayHappi pharmacy enters Assam with 70 stores
- Mumbai: Larger ITAT bench to rule on pharma freebies